These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS]. WEISS M; YVER J; SAMAMA M; DUBOST C Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607 [No Abstract] [Full Text] [Related]
3. [CLINICAL EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID AS AN ANTIFIBRINOLYTIC AGENT IN VARIOUS OBSTETRICAL DISORDERS]. PALACIO S; CANO A; YEPES E Rev Colomb Obstet Ginecol; 1964; 15():413-9. PubMed ID: 14258173 [No Abstract] [Full Text] [Related]
4. METHOD FOR DETERMINING EPSILON-AMINOCAPROIC ACID (EACA) IN BLOOD PLASMA, BASED ON THE ANTIFIBRINOLYTIC PROPERTIES OF THIS COMPOUND. WOLOSOWICZ N; NIEWIAROWSKI S; CZEREPKO K Thromb Diath Haemorrh; 1964 Jan; 10():309-16. PubMed ID: 14113373 [No Abstract] [Full Text] [Related]
5. [ON THE THERAPEUTIC USE OF EPSILON-AMINOCAPROIC ACID AND OTHER ANTIFIBRINOLYTICS]. PERLICK E Dtsch Gesundheitsw; 1964 May; 19():900-3. PubMed ID: 14220146 [No Abstract] [Full Text] [Related]
6. [A NEW METHOD OF THE ANALYSIS OF EPSILON-AMINOCAPROIC ACID (EACA) AND AMINOMETHYLCYCLOHEXANE CARBOXYLIC ACID (AMCHA), THE POTENT ANTIFIBRINOLYTIC AGENTS]. TAKATA Y; TAKATA A; OKAMOTO U Nihon Seirigaku Zasshi; 1964 May; 26():281-5. PubMed ID: 14172890 [No Abstract] [Full Text] [Related]
8. [FIBRINOLYSIS AND ANTIFIBRINOLYTIC THERAPY IN UROLOGIC OPERATIONS. EXAMINATIONS USING A NEW METHOD FOR MEASURING FIBRINOLYSIS]. PIPER W; BUCHBERGER HG; SIMON S; KRUEGER J Med Welt; 1965 Feb; 8():385-96. PubMed ID: 14262868 [No Abstract] [Full Text] [Related]
14. [EPSILON-AMINOCAPROIC ACID AND FIBRINOLYSIS]. VAIREL E; LANDE M; LEGER L Presse Med (1893); 1964 Mar; 72():945-6. PubMed ID: 14119753 [No Abstract] [Full Text] [Related]
15. [COMPARATIVE STUDY ON THE EFFECT OF EPSILON-AMINOCAPROIC ACID, ACETYL-EPSILON-AMINOCAPROIC ACID AND CAPROLACTAM FOR VARIOUS PARAMETERS OF THE FIBRINOLYTIC SYSTEM]. AUERSWALD W; DOLESCHEL W Wien Med Wochenschr; 1965 Feb; 115():102-5. PubMed ID: 14260441 [No Abstract] [Full Text] [Related]
16. [OBSERVATIONS ON ACTIVATION OF FIBRINOLYSIS IN HEMORRHAGES DUE TO TONSILLECTOMY AND ON CAUSAL TREATMENT WITH EPSILON-AMINOCAPROIC ACID]. GHILARDI F; VOENA G; BUSCA G Ann Laringol Otol Rinol Faringol; 1965; 64():55-63. PubMed ID: 14295928 [No Abstract] [Full Text] [Related]
17. [THE ROLE OF EPSILON-AMINOCAPROIC ACID IN FIBRINOLYTIC STATES]. MARCHAL G; BILSKI-PASQUIER G; SAMAMA M; CASUBOLO L Rev Clin Esp; 1964 Oct; 95():17-21. PubMed ID: 14234364 [No Abstract] [Full Text] [Related]
18. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR. NANNINGA LB; GUEST MM Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698 [No Abstract] [Full Text] [Related]